Halberd Co. (OTCMKTS:HALB) Short Interest Update

Halberd Co. (OTCMKTS:HALB) was the recipient of a large growth in short interest in May. As of May 29th, there was short interest totaling 133,008 shares, a growth of 136.4% from the May 14th total of 56,263 shares. Based on an average daily volume of 1,473,527 shares, the short-interest ratio is currently 0.1 days.

Halberd Price Performance

HALB opened at $0.00 on Friday. Halberd has a one year low of $0.00 and a one year high of $0.00.

Halberd Company Profile

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.